Dipeptidyl peptidase 4: A predictor of ferroptosis in ulcerative colitis
The Journal of Gene Medicine · 2024-10 · 26 (10)
DOI: 10.1002/jgm.3742 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Gene Medicine, online erschienen am 29.09.2024. Verfasst von Fuyun Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China. Hauptthemen laut MEDLINE: Ferroptosis, Colitis, Ulcerative, Dipeptidyl Peptidase 4, Biomarkers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Natural Scientific Fund of Chongqing Science and Technology Bureau, Graduate Student Innovation Program of Chongqing University of Technology.
Abstract (Originalsprache)
Background
With its rapidly increasing incidence and prevalence, ulcerative colitis (UC) has become a major global health challenge. Recent evidence suggests that ferroptosis plays a significant role in the development of UC. However, the relationship between ferroptosis and the progression of UC needs to be extensively studied.
Methods
The differentially expressed genes in UC patients were screened from the GEO database. The ferroptosis‐related genes were obtained from FErrDB and GeneCards. The UC subtypes were identified with the R package “CancerSubtype” and evaluated with consensus clustering (CC) to identify gene expression patterns in patients with UC. The key genes were detected with qRT‐PCR, Western blot, and immunohistochemistry in vitro and in vivo models. Ferroptosis was identified with western blotting on ferrotic‐associated proteins and staining on Fe 2+ with commercial FerroOrange kits.
Results
Dipeptidyl peptidase 4 (DPP4), also known as CD26, is a potential biomarker for ferroptosis in UC patients. Transcriptome sequencing data showed a positive correlation between decreased DPP4 expression and proinflammatory cytokines such as TNF‐α, IL‐6, and IL‐β, as well as immune cell infiltration in the colon tissues of UC patients. Furthermore, DPP4 was strongly associated with ferroptosis biomarkers, particularly in Subtype 2 of UC. Interestingly, our study also found that DPP4 expression was significantly reduced in RSL3‐treated ferroptotic intestinal epithelial cells, more so than in LPS‐treated cell models. Inhibition of DPP4 had a significant impact on the expression of ferroptotic biomarkers. Additionally, DPP4 expression was decreased in the colon tissues of DSS‐treated mice, and the ferroptosis inhibitor Ferritin‐1 effectively counteracted the effects of DSS on immune cell infiltration, colon length, and DPP4 expression.
Conclusions
DPP4 can serve as a biomarker for ferroptosis in the diagnosis and management of UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.
- Chongqing Key Laboratory of Target-Based Drug Discovery and Research, Chongqing, China.
Förderung
- Natural Scientific Fund of Chongqing Science and Technology Bureau
- Graduate Student Innovation Program of Chongqing University of Technology
Zitieren
APA
Zhu, F., Zou, D., Shi, P., Tang, L., Wu, D., Hu, X., Yin, F., & Liu, J. (2024). Dipeptidyl peptidase 4: A predictor of ferroptosis in ulcerative colitis. The Journal of Gene Medicine, 26(10). https://doi.org/10.1002/jgm.3742
Vancouver
Zhu F, Zou D, Shi P, Tang L, Wu D, Hu X, et al. Dipeptidyl peptidase 4: A predictor of ferroptosis in ulcerative colitis. The Journal of Gene Medicine. 2024;26(10). doi:10.1002/jgm.3742
BibTeX
@article{Zhu2024,
author = {Zhu, Fuyun and Zou, Dezeng and Shi, Ping and Tang, Lianhua and Wu, Dan and Hu, Xiaoxue and Yin, Fei and Liu, Jianhui},
title = {Dipeptidyl peptidase 4: A predictor of ferroptosis in ulcerative colitis},
journal = {The Journal of Gene Medicine},
year = {2024},
volume = {26},
number = {10},
doi = {10.1002/jgm.3742}
}
EUVIMED